2013 Physician Quality Reporting System Data Collection Form: Hypertension Measures Group (for patients age 18-90)

Similar documents
MY TYPE 2 DIABETES NUMBERS

High Blood Cholesterol

YOUR GUIDE TO. Managing and Understanding Your Cholesterol Levels

High Blood Cholesterol What you need to know

How To Treat Dyslipidemia

Cardiovascular Disease Risk Factors

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

SUMMARY OF CHANGES TO QOF 2015/16 - ENGLAND CLINICAL

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012

Diabetes and Stroke. Understanding the connection between diabetes and the increased risk of stroke

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY

2013 ACO Quality Measures

Guidelines for the management of hypertension in patients with diabetes mellitus

Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075

Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW

An Overview and Guide to Healthy Living with Type 2 Diabetes

ACCOUNTABLE CARE ORGANIZATION QUICK-REFERENCE SETUP GUIDE

Absolute cardiovascular disease risk management

Know your Numbers The D5 Goals for Diabetes Care. Shelly Hanson RN, CNS, CDE Cuyuna Regional Medical Center November 6, 2014

Let s talk about: Stroke

Coronary Heart Disease (CHD) Brief

Primary Care Management of Women with Hyperlipidemia. Julie Marfell, DNP, BC, FNP, Chairperson, Department of Family Nursing

Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology

Diabetes and Your Kidneys

Cholesterol and Triglycerides What You Should Know

Cohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University

Rx Updates New Guidelines, New Medications What You Need to Know

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE

High Blood Pressure and Your Kidneys

Cardiovascular Risk in Diabetes

Absolute cardiovascular disease risk assessment

HIGH BLOOD PRESSURE AND YOUR KIDNEYS

Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT

CDS Starter Kit: Diabetes f ollow-up care

High Blood Pressure (Essential Hypertension)

Radiology Business Management Association Technology Task Force. Sample Request for Proposal

Diabetes and Heart Disease

CORPORATE HEALTH LOWERING YOUR CHOLESTEROL & BLOOD PRESSURE

Improving cardiometabolic health in Major Mental Illness

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

Health Maintenance: Controlling Cholesterol

OBJECTIVES AGING POPULATION AGING POPULATION AGING IMPACT ON MEDICARE AGING POPULATION

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES

DIABETES MELLITUS GUIDELINES

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

Practice Guidelines for the

Diabetes, Type 2. RelayClinical Patient Education Sample Topic Diabetes, Type 2. What is type 2 diabetes? How does it occur?

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis

Blood Pressure Assessment Program Screening Guidelines

Psychiatrists and Reporting on Meaningful Use Stage 1. August 6, 2012

Improving Healthcare Quality for the Underserved: A Davies Story Angela Duncan Diop, ND Unity Health Care, Inc. Washington, DC

A Calorie is a Calorie Or is It? 6 th Biennial Childhood Obesity Conference, June 30, 2011

Mar. 31, 2011 (202) Improving Quality of Care for Medicare Patients: Accountable Care Organizations

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

Division for Heart Disease and Stroke Prevention Million Hearts Clinical Quality Measures Dashboard

Type 2 diabetes Definition

Sinclair Community College, Division of Allied Health Technologies

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

MEDICAL NUTRITION THERAPY (MNT) CLINICAL NUTRITION THERAPY Service Time CPT Code

Daily Diabetes Management Book

Absolute cardiovascular disease risk

Heart Healthy Living

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better

Mississippi Delta Health Collaborative Mississippi State Department of Health 1

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence

Pharmacy and the Medicaid Accountable Care Organization

Your Results. For more information visit: Name: Date: In partnership with

Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases

Improving Quality of Care for Medicare Patients: Accountable Care Organizations

ABELMed EHR-EMR/PM version 12, an ONC HIT 2014 Edition Complete EHR, has been certified for the following 42 clinical quality measures (CQMs).

WHO STEPwise approach to chronic disease risk factor surveillance (STEPS)

Appendix: Description of the DIETRON model

EUROASPIRE II. European Action on Secondary and Primary Prevention through Intervention to Reduce Events

Evidence-Based Secondary Stroke Prevention and Adherence to Guidelines

Medicare Physician Group Practice Demonstration

Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).

High Blood Pressure in People with Diabetes:

Medicare Shared Savings Program Quality Measure Benchmarks for the 2014 Reporting Year

Electronic Health Record Strategies for Pay for Performance. James O Connor MD Director of Clinical Informatics

What is a Heart Attack? 1,2,3

Main Effect of Screening for Coronary Artery Disease Using CT

Facts About Peripheral Arterial Disease (P.A.D.)

Understanding diabetes Do the recent trials help?

Anticoagulants in Atrial Fibrillation

Risk estimation and the prevention of cardiovascular disease. A national clinical guideline

1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME

PHYSICIAN ORDERS TRANSIENT ISCHEMIC ATTACK (TIA) OBSERVATION

Vascular Risk Reduction: Addressing Vascular Risk

Preventive Care Recommendations THE BASIC FACTS

ATLANTIC and OPTIMUS ACCOUNTABLE CARE ORGANIZATIONs CMS QUALITY MEASURES

High Blood Pressure and Chronic Kidney Disease. For People With CKD Stages 1 4

ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE

ACO Name and Location Allina Health Minneapolis, Minnesota

African Americans & Cardiovascular Diseases

Transcription:

2013 Physician Quality Reporting System Data Collection Form: Hypertension Measures Group (for patients age 18-90) Physician Name: Patient Name: Last First MI Gender: Patient Insured - M F Traditional Medicare*: Medicare Advantage: Other: Date of Birth: / / mm dd yyyy Medical Record Number: App t Date: / / mm dd yyyy ICD-9 : Encounter: *Note: A minimum of 11 patients must be Traditional Medicare Part B Patient sample criteria for the Hypertension Measures Group are patients aged 18 through 90 years with a specific diagnosis of hypertension, and without a diagnosis of stage 5 chronic kidney disease (GFR of < 15ml/min per 1.72 m2 or end-stage kidney disease) accompanied by a specific patient encounter: One of the following diagnosis codes indicating Hypertension: 401.0, 401.1, 401.9, 402.00, 402.01, 402.10, 402.11, 402.90, 402.91, 403.00, 403.10, 403.11, 403.90, 404.00, 404.01, 404.10, 404.11, 404.90, 404.91 Accompanied by one of the following patient encounter codes: 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99324, 99325, 99326, 99327, 99328, 99334, 99335, 99336, 99337, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, G0438, G0439 AND NOT Diagnosis for stage 5 chronic kidney disease (ICD-9-CM): 585.5, 585.6, 403.01, 403.91, 404.02, 404.03, 404.12, 404.13, 404.92, 404.93 The appointment date must be between Jan 1 through Dec 31, 2013. Each measure needs to have been assessed at least once during the 12 month reporting period. If more than one assessment; record the most recent information. PLEASE REFER TO THE HYPERTENSION USER GUIDE FOR FURTHER INFORMATION

Patient Name: Page 2 of 7 Physician Quality Reporting Measure # 300 : Hypertension: Blood Pressure Control diagnosis of hypertension who had most recent blood pressure level under control (at goal) within 12 months Patients are considered to have most recent blood pressure under control if any of the following are documented: < 130/80 mmhg for those with chronic kidney disease OR diabetes < 140/90 mmhg for those without conditions listed above If there are multiple blood pressures on the same date of service, use the lowest systolic and lowest diastolic blood pressure on that date as the representative blood pressure. To be under control, both systolic and diastolic blood pressures must be below the target values (e.g., for a diabetes patient, systolic BP =136 mmhg and diastolic BP =70 mmhg is not under control ). Most recent blood pressure under control most recent blood pressure not under control (e.g., patients with palliative or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) Most recent blood pressure not under control, results documented and reviewed Blood pressure measurement not performed, reason not given

Patient Name: Page 3 of 7 Physician Quality Reporting Measure # 301 : Hypertension: Low Density Lipoprotein (LDL-C) Control diagnosis of hypertension who had most recent LDL cholesterol level under control (at goal) within 60 months Patients are considered to have most recent LDL-C level under control if any of the following are documented: < 100 mg/dl for those with coronary heart disease, OR stroke or transient ischemic attack, OR peripheral artery disease, OR diabetes < 130 mg/dl for those without conditions listed above, but with one or more additional risk factors for CHD (Low HDL (< 40 mg/dl) or on HDL-raising medication, risk age (men 45, women 55), family history of premature CHD, smoking); HDL cholesterol 60 acts as a negative risk factor < 160 mg/dl for those without conditions listed above, and without additional risk factors for CHD (Low HDL (< 40 mg/dl) or on HDL-raising medication, risk age (men 45, women 55), family history of premature CHD, smoking); HDL cholesterol 60 acts as a negative risk factor most appropriate of the two Documentation of medical reasons boxes in table to the right). Most recent LDL-C under control, results documented and reviewed most recent LDL-C not under control (e.g., patients with palliative or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) not performing LDL-C test (e.g., patients with palliative or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) Most recent LDL-C not under control, results documented and reviewed LDL-C not performed, reason not given

Patient Name: Page 4 of 7 Physician Quality Reporting Measure # 295 : Hypertension: Appropriate Use of Aspirin or Other Antithrombotic Therapy Percentage of patients aged 30 through 90* years old with a diagnosis of hypertension who were prescribed aspirin or other antithrombotic therapy Oral antiplatelet therapy consists of aspirin, warfarin, clopidogrel, dabigratan, or combination of aspirin and extended release dipyridamole. Diagnosis of prior coronary heart disease, prior stroke or transient ischemic attack, prior peripheral artery disease, and/or prior diabetes, and Framingham risk assessment for estimating 10-year risk of developing CHD are used to determine whether a patient should be prescribed aspirin or other anticoagulant/antiplatelet therapy. goals is not clinically appropriate, or with low risk for CHD, should be excluded (check Documentation of medical reasons box in table to the right). Prescribed - May include prescription given to the patient for aspirin or other anticoagulant/antiplatelet at one or more visits in the 12 month period OR patient already taking aspirin, warfarin, clopidogrel, dabigratan, or combination of aspirin and extended release dipyridamole as documented in current medication list. * Measure 295 is applicable only to patients 30-90 years within the sample population, while all other measures within this group apply to all patients 18-90 years. Oral aspirin or other antithrombotic therapy prescribed prescribing oral aspirin or other antithrombotic therapy (e.g., patient documented to be low risk, or patient with palliative care goals or treatment of hypertension with standard treatment goals is not clinically appropriate, or for whom risk of aspirin or other antithrombotic therapy exceeds potential benefits such as for individuals whose blood pressure is poorly controlled) Oral aspirin or other antithrombotic therapy was not prescribed, reason not given

Patient Name: Page 5 of 7 Physician Quality Reporting Measure # 296 : Hypertension: Complete Lipid Profile diagnosis of hypertension who received a complete lipid profile within 60 months If LDL-C could not be calculated due to high triglycerides, count as complete lipid profile. Lipid panel results documented and reviewed (must include total cholesterol, HDL-C, triglycerides and calculated LDL-C) performing lipid profile (e.g., patients with palliative or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) Lipid profile not performed, reason not given Physician Quality Reporting Measure # 297 : Hypertension: Urine Protein Test diagnosis of hypertension who either have chronic kidney disease diagnosis documented or had a urine protein test done within 36 months This measure is looking for a urine protein screening test or evidence of existing chronic kidney disease. A urine protein test consists of tests for albuminuria, microalbuminuria, or proteinuria. Urine Protein test result documented and reviewed Documentation of diagnosis of chronic kidney disease performing urine protein test (e.g., patients with palliative or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) Urine protein test was not performed, reason not given

Patient Name: Page 6 of 7 Physician Quality Reporting Measure # 298 : Hypertension: Annual Serum Creatinine Test diagnosis of hypertension who had a serum creatinine test done within 12 months Serum creatinine test result documented and reviewed performing serum creatinine test (e.g., patients with palliative or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) Serum creatinine test not performed, reason not given Physician Quality Reporting Measure # 299 : Hypertension: Diabetes Mellitus Screening Test diagnosis of hypertension who had a diabetes screening test within 36 months Diabetes screening test consists of either a fasting glucose measurement, glycosylated hemoglobin test, or a two hour glucose tolerance test (three specimens). Diabetes screening test performed performing diabetes screening test (e.g., patients with palliative or for whom treatment of hypertension with standard treatment goals is not clinically appropriate, OR patients with a diagnosis of diabetes) Diabetes screening test not performed, reason not given

Patient Name: Page 7 of 7 Physician Quality Reporting Measure # 302 : Hypertension: Dietary and Physical Activity Modifications Appropriately Prescribed diagnosis of hypertension who received dietary and physical activity counseling at least once within 12 months Patients who have a terminal illness or for whom treatment of hypertension with standard treatment goals is not clinically appropriate should be excluded (check Documentation of medical reasons box in table to the right). For some patients, treatment of hypertension with standard goals may not be relevant, as might be the case for a patient with severe Alzheimer s disease. Counseling May include documentation of prescribing any of the following dietary modifications: dietary saturated fat and cholesterol restriction, calorie restriction as part of weight reduction program for overweight/obese patients, DASH eating plan, dietary sodium restriction, increased fruits, vegetables and/or soluble fiber; and documentation of activity status for active patients or discussion of increase exercise or physical activity for inactive patients. Counseling for diet and physical activity performed patient not receiving counseling for diet and physical activity (e.g., patients with palliative or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) Documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e.g., patient is not willing to discuss diet or exercise interventions to help control blood pressure, or the patient said he/she refused to make these changes) Counseling for diet and physical activity not performed, reason not given